Berar-Yanay, N.; Freiman, S.; Shapira, M.; Saffoury, A.; Elemy, A.; Hamze, M.; Elhaj, M.; Zaher, M.; Matanis, L.; Armaly, Z.A.
Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients. J. Clin. Med. 2022, 11, 64.
https://doi.org/10.3390/jcm11010064
AMA Style
Berar-Yanay N, Freiman S, Shapira M, Saffoury A, Elemy A, Hamze M, Elhaj M, Zaher M, Matanis L, Armaly ZA.
Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients. Journal of Clinical Medicine. 2022; 11(1):64.
https://doi.org/10.3390/jcm11010064
Chicago/Turabian Style
Berar-Yanay, Noa, Sarit Freiman, Maʹanit Shapira, Amer Saffoury, Ameer Elemy, Munir Hamze, Mohamad Elhaj, Maha Zaher, Loai Matanis, and Zaher Anis Armaly.
2022. "Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients" Journal of Clinical Medicine 11, no. 1: 64.
https://doi.org/10.3390/jcm11010064
APA Style
Berar-Yanay, N., Freiman, S., Shapira, M., Saffoury, A., Elemy, A., Hamze, M., Elhaj, M., Zaher, M., Matanis, L., & Armaly, Z. A.
(2022). Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients. Journal of Clinical Medicine, 11(1), 64.
https://doi.org/10.3390/jcm11010064